Adoptive Therapy with Chimeric Antigen Receptor Modified T Cells of Defined Subset Composition

The ability to engineer T cells to recognize tumor cells through genetic modification with a synthetic chimeric antigen receptor has ushered in a new era in cancer immunotherapy. The most advanced clinical applications are in in targeting CD19 on B cell malignancies. The clinical trials of CD19 CAR...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Riddell, Stanley R., Sommermeyer, Daniel, Berger, Carolina, Liu, Lingfeng (Steven), Balakrishnan, Ashwini, Salter, Alex, Hudecek, Michael, Maloney, David G., Turtle, Cameron J.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2014
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4149222/
https://ncbi.nlm.nih.gov/pubmed/24667960
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/PPO.0000000000000036
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller